đź“‹ FDA Reference

Starclose Se R Vascular Surgical System

Abbott Vascular Devices

Compare similar devices

Summary: The StarClose SE R Vascular Surgical System is a device used for vascular closure following catheterization procedures. It is primarily used by interventional cardiologists and radiologists to achieve hemostasis quickly and effectively.

FDA Clearance Information

Pathway ? PMA
Number ? P050007 ↗
Decision Date ? February 10, 2025
Product Code ? MGB Device, Hemostasis, Vascular
Device Class ? Class 3
Evidence ? 2 studies

The StarClose SE R received FDA clearance under PMA P050007 on February 10, 2025. Manufactured by Abbott Vascular Devices, it is classified as a Class 3 medical device.

What It Is

The StarClose SE R Vascular Surgical System is a vascular closure device designed to close femoral artery access sites following catheterization procedures. It works by deploying a small nitinol clip to mechanically close the puncture site, promoting rapid hemostasis. This device is particularly useful in reducing time to ambulation and discharge for patients undergoing diagnostic or interventional procedures.

FDA-Cleared Indications

  • The FDA record identifies approval for a manufacturing site to perform sterilization of the StarClose SE R Vascular Surgical System.
  • The device is associated with closure of femoral artery access sites following catheterization procedures, according to the product description and device classification.

Clinical Applications

  • Closure of a femoral artery puncture site after diagnostic catheterization.
  • Closure of a femoral artery access site after an interventional cardiology procedure.
  • Closure of a femoral artery access site after a peripheral vascular intervention.

Practical Considerations

  • The system is intended for use at femoral arterial access sites; vessel anatomy and puncture location should be evaluated before deployment.
  • Use requires appropriate imaging or procedural assessment to confirm access-site anatomy and suitability for a vascular closure device.
  • Clinicians should follow the current FDA-approved labeling for access-site requirements, compatible sheath sizes, deployment technique, and contraindications.
  • Potential complications include bleeding, hematoma, infection, arterial stenosis or occlusion, pseudoaneurysm, and failure of hemostasis.
  • MRI safety depends on the implanted nitinol clip and the current product labeling; confirm the device's MR conditions before an MRI examination.

Linked Studies (2)

PubMed • 2012

The use of the StarClose device for obtaining femoral artery hemostasis.

Vascular and endovascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2006

Use of the profunda femoris to facilitate closure of an antegrade puncture with the StarClose device after proximal SFA angioplasty.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

Other View Source →

Frequently Asked Questions

What is StarClose SE R used for?

The StarClose SE R is used for closing femoral artery access sites following catheterization procedures to achieve hemostasis.

What specialties typically use this device?

Interventional cardiologists and radiologists typically use the StarClose SE R for vascular closure after catheter-based procedures.

What are the FDA-cleared indications?

The device is indicated for use in closing femoral artery access sites post-catheterization to achieve rapid hemostasis.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you